Feed / ENSG

The Ensign Group, Inc.

ENSG

Healthcare · 172.02 -0.1% today

Participation confirmed · construction unavailableMarket checked 2 Oct, 15:45 GMT-4

Market read

The Ensign Group, Inc.'s move is spreading beyond its market group.

The latest filing evidence is available. 12 of 14 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 3 directly disclosed connections are confirming.

What changed
  • Revenue increased 18.4% versus the comparable filing period.
Company-0.1% todayVolume comparison unavailable
Market group12 of 14 activeHealthcare REITs · active
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 10 of 14 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • SVC remains aligned with the group in the next market snapshot.

Invalidation: The live read weakens if participation falls to 4 of 14 members or fewer.

Watch this read

Research brief

The story so far

Healthcare · Medical Care Facilities

The latest filing evidence is available. 12 of 14 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 3 directly disclosed connections are confirming.

Evidence that supports
  • Revenue increased 18.4% versus the comparable filing period.
  • Net income increased 24.2% versus the comparable filing period.
  • Operating cash flow covered net income at 1.00x, improving versus the comparable period.
Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • At least 10 of 14 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • SVC remains aligned with the group in the next market snapshot.

Company research

Understand the business, not just the ticker

As of Oct 2, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations342
Usable filing statements155
Verified relationships3
Evidence supporting the case
  • Latest annual revenue changed +18.8% year over year.
  • Operating cash flow covered net income at 1.64x in the latest annual period.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Oct 1, 2026

169.65
6m-15.2%12m-1.8%24m—
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$2.6B+10.1%$3.42+2.0%
2022-12-31$3.0B+15.1%$3.95-0.1%
2023-12-31$3.7B+22.6%$3.65+0.8%
2024-12-31$4.2B+14.3%$5.12+1.6%
2025-12-31$5.0B+18.8%$5.84+1.1%

What management says matters

Persistent and emerging business drivers

Capital investment and capacitymixed · 4 filings
“71 Table of Contents The $167.0 million increase in cash used in investing activities for the six months ended June 30, 2026 compared to the same period in 2025 was primarily used for acquisitions, partially offset by maturities of our investments and reduced…”
10-Q · Jul 27, 2026 ↗
Credit and interest ratesmixed · 4 filings
“58 Table of Contents We calculate EBITDA as net income, adjusted for net losses attributable to noncontrolling interest, before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization, and (d) interest expense.”
10-Q · Jul 27, 2026 ↗
Legal and regulatory exposurenegative · 4 filings
“Some of our independent subsidiaries have been or will be in denial of payment status due to findings of continued regulatory deficiencies, resulting in an actual loss of revenue associated with patients admitted after the denial of payment date.”
10-Q · Apr 30, 2026 ↗
Demand and volumemixed · 1 filings
“Increased Demand Driven by Aging Populations — As seniors account for an increasing percentage of the total U.S.”
10-K · Feb 4, 2026 ↗

Valuation discipline

Descriptive valuation snapshot

Price/sales 2.0× · EV/sales 1.9×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

172.02-0.1% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 2 Oct, 15:45 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for ENSG. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Latest filing assessment · baseline

Fundamentals strengthened in the latest filing

10-Q filed 2026-04-30 against the comparable filing from 2025-04-29.

constructive
OperationsconstructiveEvidence score +3
liquidityconstructiveEvidence score +1
valuationmixed

What improved

  • Revenue increased 18.4% versus the comparable filing period.
  • Net income increased 24.2% versus the comparable filing period.
  • Operating cash flow covered net income at 1.00x, improving versus the comparable period.

What weakened

No thresholded deterioration was identified.

Filing receipts

“Cost of services as a percentage of revenue decreased by 0.3% to 79.1% reflecting continued cost management, a shift towards higher acuity as we serve more clinically complex patients, and improving operational performance at our newer acquisitions.”

“This increase was primarily related to the additional depreciation incurred as a result of our newly acquired operations, which have a greater mix of real estate purchases than leases, and capital investments.”

“Other income, net decreased by $1.5 million due primarily due to a $1.7 million loss on our deferred compensation plan and a decrease in interest income of $0.3 million as we utilized our cash on hand to fund more real estate purchases during the period coupled with a lower interest rate environment.”

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Business ecosystem

The relationships behind ENSG

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CTRECareTrust REIT, Inc.partnerApr 30, 2026 ▾

“Operating Leases As of March 31, 2026, 254 of our facilities have long-term lease arrangements, of which 104 of the operations are under eight triple-net Master Leases with CareTrust.”

CTRECareTrust REIT, Inc.investeeJul 24, 2025 ▾

“During the six months ended June 30, 2025, we, through Standard Bearer, exercised the option to purchase the real estate of four facilities from CareTrust for $44.6 million.”

TFCTruist Financial CorporationlenderApr 30, 2026 ▾

“59 Table of Contents Credit Facility with a Lending Consortium Arranged by Truist We maintain a revolving credit facility with Truist Securities (Truist) (the Credit Facility) with availability of up to $600.0 million in aggregate principal.”

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ENSG is currently a Participant in the organic co-movement group Healthcare REITs. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.